Comparison of electrophysiologic effects and uses of new and standard antiarrhythmic agents

D. P. Zipes

Research output: Contribution to journalArticle

Abstract

The four classes of antiarrhythmic agents are reviewed, and electrophysiologic effects of selected drugs are discussed. Classification is based on the degree to which an antiarrhythmic agent affects the fast sodium channel, adrenergic response, repolarization of myocardial cells, and the slow calcium channel. Class 1 drugs interfere with the sodium channel and are subgrouped according to the potency of this effect. Class 1A drugs (quinidine, procainamide, disopyramide) prolong refractoriness and have a moderate effect on the sodium channel. Class 1B drugs (lidocaine, phenytoin, tocainide, mexiletine) exert less effect on the sodium channel and tend to shorten rather than prolong refractoriness. Class 1C drugs (encainide, flecainide, lorcainide, and propafenone) have a marked effect on the sodium channel and a minimal effect on repolarization. The β blockers, class 2 drugs, have antiadrenergic properties, and the class 3 drugs (amiodarone, sotalol, bretylium) affect repolarization and markedly prolong refractoriness, action potential duration, and the QT interval. The slow inward calcium current is blocked by class 4 drugs (verapamil, diltiazem). Classification of individual drugs is highly artificial. Despite limitations of the classification scheme, the system provides a useful framework for comparisons among antiarrhythmic agents.

Original languageEnglish
Pages (from-to)6-9
Number of pages4
JournalClinical Pharmacy
Volume6
Issue number3 II
StatePublished - 1987

Fingerprint

Sodium Channels
Pharmaceutical Preparations
lorcainide
Encainide
Tocainide
Propafenone
Mexiletine
Flecainide
Disopyramide
Sotalol
Procainamide
Adrenergic Antagonists
Quinidine
Amiodarone
Diltiazem
Phenytoin
Calcium Channels
Verapamil
Lidocaine
Adrenergic Agents

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Comparison of electrophysiologic effects and uses of new and standard antiarrhythmic agents. / Zipes, D. P.

In: Clinical Pharmacy, Vol. 6, No. 3 II, 1987, p. 6-9.

Research output: Contribution to journalArticle

@article{70197d2f967241c1bcd45e1390771536,
title = "Comparison of electrophysiologic effects and uses of new and standard antiarrhythmic agents",
abstract = "The four classes of antiarrhythmic agents are reviewed, and electrophysiologic effects of selected drugs are discussed. Classification is based on the degree to which an antiarrhythmic agent affects the fast sodium channel, adrenergic response, repolarization of myocardial cells, and the slow calcium channel. Class 1 drugs interfere with the sodium channel and are subgrouped according to the potency of this effect. Class 1A drugs (quinidine, procainamide, disopyramide) prolong refractoriness and have a moderate effect on the sodium channel. Class 1B drugs (lidocaine, phenytoin, tocainide, mexiletine) exert less effect on the sodium channel and tend to shorten rather than prolong refractoriness. Class 1C drugs (encainide, flecainide, lorcainide, and propafenone) have a marked effect on the sodium channel and a minimal effect on repolarization. The β blockers, class 2 drugs, have antiadrenergic properties, and the class 3 drugs (amiodarone, sotalol, bretylium) affect repolarization and markedly prolong refractoriness, action potential duration, and the QT interval. The slow inward calcium current is blocked by class 4 drugs (verapamil, diltiazem). Classification of individual drugs is highly artificial. Despite limitations of the classification scheme, the system provides a useful framework for comparisons among antiarrhythmic agents.",
author = "Zipes, {D. P.}",
year = "1987",
language = "English",
volume = "6",
pages = "6--9",
journal = "Clinical Pharmacy",
issn = "0278-2677",
publisher = "American Society of Hospital Pharmacists",
number = "3 II",

}

TY - JOUR

T1 - Comparison of electrophysiologic effects and uses of new and standard antiarrhythmic agents

AU - Zipes, D. P.

PY - 1987

Y1 - 1987

N2 - The four classes of antiarrhythmic agents are reviewed, and electrophysiologic effects of selected drugs are discussed. Classification is based on the degree to which an antiarrhythmic agent affects the fast sodium channel, adrenergic response, repolarization of myocardial cells, and the slow calcium channel. Class 1 drugs interfere with the sodium channel and are subgrouped according to the potency of this effect. Class 1A drugs (quinidine, procainamide, disopyramide) prolong refractoriness and have a moderate effect on the sodium channel. Class 1B drugs (lidocaine, phenytoin, tocainide, mexiletine) exert less effect on the sodium channel and tend to shorten rather than prolong refractoriness. Class 1C drugs (encainide, flecainide, lorcainide, and propafenone) have a marked effect on the sodium channel and a minimal effect on repolarization. The β blockers, class 2 drugs, have antiadrenergic properties, and the class 3 drugs (amiodarone, sotalol, bretylium) affect repolarization and markedly prolong refractoriness, action potential duration, and the QT interval. The slow inward calcium current is blocked by class 4 drugs (verapamil, diltiazem). Classification of individual drugs is highly artificial. Despite limitations of the classification scheme, the system provides a useful framework for comparisons among antiarrhythmic agents.

AB - The four classes of antiarrhythmic agents are reviewed, and electrophysiologic effects of selected drugs are discussed. Classification is based on the degree to which an antiarrhythmic agent affects the fast sodium channel, adrenergic response, repolarization of myocardial cells, and the slow calcium channel. Class 1 drugs interfere with the sodium channel and are subgrouped according to the potency of this effect. Class 1A drugs (quinidine, procainamide, disopyramide) prolong refractoriness and have a moderate effect on the sodium channel. Class 1B drugs (lidocaine, phenytoin, tocainide, mexiletine) exert less effect on the sodium channel and tend to shorten rather than prolong refractoriness. Class 1C drugs (encainide, flecainide, lorcainide, and propafenone) have a marked effect on the sodium channel and a minimal effect on repolarization. The β blockers, class 2 drugs, have antiadrenergic properties, and the class 3 drugs (amiodarone, sotalol, bretylium) affect repolarization and markedly prolong refractoriness, action potential duration, and the QT interval. The slow inward calcium current is blocked by class 4 drugs (verapamil, diltiazem). Classification of individual drugs is highly artificial. Despite limitations of the classification scheme, the system provides a useful framework for comparisons among antiarrhythmic agents.

UR - http://www.scopus.com/inward/record.url?scp=0023276272&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023276272&partnerID=8YFLogxK

M3 - Article

VL - 6

SP - 6

EP - 9

JO - Clinical Pharmacy

JF - Clinical Pharmacy

SN - 0278-2677

IS - 3 II

ER -